Vote!
Med Sci Monit 2012; 18(3):PI11-15 "Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment"
Conclusions: Our study gives a different perspective on severe persistent allergic asthma and omalizumab treatment efficacy at the cell apoptosis-linked step by the serum sTRAIL levels. (Source: Medical Science Monitor)...
Published By: MedWorm - Wednesday, 22 February